MUC5AC: A potential biomarker of severity in pediatric patients infected with influenza
- PMID: 38808542
- DOI: 10.1002/jmv.29715
MUC5AC: A potential biomarker of severity in pediatric patients infected with influenza
Abstract
Numerous factors can increase the risk of severe influenza; however, a majority of severe cases occur in previously healthy children. Identification of high-risk children is important for targeted preventive interventions and prompt treatment. The aim of this study was to evaluate MUC5AC as a biomarker for influenza disease severity in children. For this, a prospective cohort study was conducted in 2019. Children hospitalized with acute respiratory infection (ARI) with confirmed positive influenza infection were enrolled. Influenza cases were identified by reverse transcriptase-polymerase chain reaction. Life-threatening disease (LTD) was defined by the need for intensive care and ventilatory support. MUC5AC, epidemiologic, and clinical risk factors were assessed. Three hundred and forty-two patients were hospitalized with ARI, of which 49 (14%) had confirmed influenza infection and 6 (12%) of them developed LTD. MUC5AC levels were higher in those patients with mild disease compared to cases with poorer outcomes. Our results show that the severity of influenza infection in children is significantly associated with low levels of MUC5AC. These findings suggest its potential as a suitable biomarker for predicting disease severity.
Keywords: MUC5AC; influenza; life‐threatening disease.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- World Health Organization. Influenza. WHO; 2017. https://www.who.int/news/item/13-12-2017-up-to-650-000-people-die-of-res...
-
- Wang X, Li Y, O'Brien KL, et al. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020;8:e497‐e510.
-
- Li Y, Tang XX. Abnormal airway mucus secretion induced by virus infection. Front Immunol. 2021;12:701443.
-
- Ehre C, Worthington EN, Liesman RM, et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc Natl Acad Sci USA. 2012;109:16528‐16533.
-
- Rajan D, O'Keefe EL, Travers C, et al. MUC5AC levels associated with respiratory syncytial virus disease severity. Clin Infect Dis. 2018;67(9):1441‐1444.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
